281
Views
16
CrossRef citations to date
0
Altmetric
Article

A Licorice Roots Extract Induces Apoptosis and Cell Cycle Arrest and Improves Metabolism via Regulating MiRNAs in Liver Cancer Cells 

, , , & ORCID Icon
Pages 1047-1058 | Received 27 Mar 2020, Accepted 09 Jun 2020, Published online: 24 Jun 2020

References

  • Costello LC, Franklin RB. The genetic/metabolic transformation concept of carcinogenesis. Cancer Metastasis Rev. 2012;31(1-2):123–130. doi:10.1007/s10555-011-9334-8
  • Warburg O. On the origin of cancer cells. Science. 1956;123(3191):309–314. doi:10.1126/science.123.3191.309
  • Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–674. doi:10.1016/j.cell.2011.02.013
  • Pierotti MA, Berrino F, Gariboldi M, Melani C, Mogavero A, Negri T, Pasanisi P, Pilotti S. Targeting metabolism for cancer treatment and prevention: metformin, an old drug with multi-faceted effects. Oncogene. 2013;32(12):1475–1487. doi:10.1038/onc.2012.181
  • Pollak MN. Investigating metformin for cancer prevention and treatment: the end of the beginning. Cancer Discov. 2012;2(9):778–790. doi:10.1158/2159-8290.CD-12-0263
  • Tabatabaei-Malazy O, Larijani B, Abdollahi M. Targeting metabolic disorders by natural products. J Diabetes Metab Disord. 2015;14(1):57. doi:10.1186/s40200-015-0184-8
  • Gao J-L, Chen Y-G. Natural compounds regulate glycolysis in hypoxic tumor microenvironment. Biomed Res Int. 2015;2015:354143. doi:10.1155/2015/354143
  • Pavlova NN, Thompson CB. The emerging hallmarks of cancer metabolism. Cell Metab. 2016;23(1):27–47. doi:10.1016/j.cmet.2015.12.006
  • Phan LM, Yeung S-C, Lee M-H. Cancer metabolic reprogramming: importance, main features, and potentials for precise targeted anti-cancer therapies. Cancer Biol Med. 2014;11(1):1475–1487.
  • Zhong Z, Qiang WW, Tan W, Zhang H, Wang S, Wang C, Qiang W, Wang Y. Chinese herbs interfering with cancer reprogramming metabolism. Evidence Based Complement Altern Med. 2016;2016:1–10. doi:10.1155/2016/9282813
  • Zhao Y, Butler EB, Tan M. Targeting cellular metabolism to improve cancer therapeutics. Cell Death Dis. 2013;4(3):e532. doi:10.1038/cddis.2013.60
  • Harding V, Stebbing J. Liquorice: a treatment for all sorts? Lancet Oncol. 2017;18(9):1155. doi:10.1016/S1470-2045(17)30628-9
  • Asl MN, Hosseinzadeh H. Review of pharmacological effects of Glycyrrhiza sp. and its bioactive compounds. Phytother Res. 2008;22(6):709–724. doi:10.1002/ptr.2362
  • Wang ZY, Nixon DW. Licorice and cancer. Nutr Cancer. 2001;39(1):1–11. doi:10.1207/S15327914nc391_1
  • Yang R, Wang L, Liu Y. Antitumor activities of widely-used Chinese herb—licorice. Chinese Herb Med. 2014;6(4):274–281. doi:10.1016/S1674-6384(14)60042-3
  • Iorio MV, Croce CM. MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol Med. 2012;4(3):143–159. doi:10.1002/emmm.201100209
  • Pulito C, Donzelli S, Muti P, Puzzo L, Strano S, Blandino G. microRNAs and cancer metabolism reprogramming: the paradigm of metformin. Ann Transl Med. 2014;2(6):58.
  • Chen B, Li H, Zeng X, Yang P, Liu X, Zhao X, Liang S. Roles of microRNA on cancer cell metabolism. J Transl Med. 2012;10(1):228. doi:10.1186/1479-5876-10-228
  • Lin Q, Ma L, Liu Z, Yang Z, Wang J, Liu J, Jiang G. Targeting microRNAs: a new action mechanism of natural compounds. Oncotarget. 2017;8(9):15961–15970. doi:10.18632/oncotarget.14392
  • Phuah NH, Nagoor NH. Regulation of microRNAs by natural agents: new strategies in cancer therapies. Biomed Res Int. 2014;2014:804510. doi:10.1155/2014/804510
  • Abdo W, Hirata A, Shukry M, Kamal T, Abdel-Sattar E, Mahrous E, Yanai T. Calligonum comosum extract inhibits diethylnitrosamine-induced hepatocarcinogenesis in rats. Oncol Lett. 2015;10(2):716–722. doi:10.3892/ol.2015.3313
  • Elbanna AH, Nooh MM, Mahrous EA, Khaleel AE, Elalfy TS. Extract of Bauhinia vahlii shows antihyperglycemic activity, reverses oxidative stress, and protects against liver damage in streptozotocin-induced diabetic rats. Pharmacogn Mag. 2017;13(Suppl 3):S607–S612. doi:10.4103/pm.pm_4_17
  • Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65(1-2):55–63. doi:10.1016/0022-1759(83)90303-4
  • Dean PN, Jett JH. Mathematical analysis of DNA distributions derived from flow microfluorometry. J Cell Biol. 1974;60(2):523–527. doi:10.1083/jcb.60.2.523
  • Zhou K, Liu M, Cao Y. New insight into microRNA functions in cancer: oncogene-microRNA-tumor suppressor gene network. Front Mol Biosci. 2017;4:46. doi:10.3389/fmolb.2017.00046
  • Svoronos AA, Engelman DM, Slack FJ. OncomiR or tumor suppressor? The duplicity of microRNAs in cancer. Cancer Res. 2016;76(13):3666–3670. doi:10.1158/0008-5472.CAN-16-0359
  • Wang J, Zhang Y-S, Thakur K, Hussain SS, Zhang J-G, Xiao G-R, Wei Z-J. Licochalcone A from licorice root, an inhibitor of human hepatoma cell growth via induction of cell apoptosis and cell cycle arrest. Food Chem Toxicol. 2018;120:407–417. doi:10.1016/j.fct.2018.07.044
  • Rafi MM, Vastano BC, Zhu N, Ho C-T, Ghai G, Rosen RT, Gallo MA, DiPaola RS. Novel polyphenol molecule isolated from licorice root (Glycyrrhiza glabra) induces apoptosis, G2/M cell cycle arrest, and Bcl-2 phosphorylation in tumor cell lines. J Agric Food Chem. 2002;50(4):677–684. doi:10.1021/jf010774e
  • Guo Y, Xiao Z, Yang L, Gao Y, Zhu Q, Hu L, Huang D, Xu Q. Hypoxia‑inducible factors in hepatocellular carcinoma (Review). Oncol Rep. 2020;43(1):3–15. doi:10.3892/or.2019.7397
  • Li B, He L, Zuo D, He W, Wang Y, Zhang Y, Liu W, Yuan Y. Mutual regulation of MiR-199a-5p and HIF-1α modulates the Warburg effect in hepatocellular carcinoma. J Cancer. 2017;8(6):940–949. doi:10.7150/jca.17496
  • Jiao M, Nan K-J. Activation of PI3 kinase/Akt/HIF-1α pathway contributes to hypoxia-induced epithelial-mesenchymal transition and chemoresistance in hepatocellular atocellular carcinoma. Int J Oncol. 2012;40(2):461–468. doi:10.3892/ijo.2011.1197
  • Zadra G, Batista JL, Loda M. Dissecting the dual role of AMPK in cancer: from experimental to human studies. Mol Cancer Res. 2015;13(7):1059–1072. doi:10.1158/1541-7786.MCR-15-0068
  • Wenner CE. Targeting mitochondria as a therapeutic target in cancer. J Cell Physiol. 2012;227(2):450–456. doi:10.1002/jcp.22788
  • Guo W, Qiu Z, Wang Z, Wang Q, Tan N, Chen T, Chen Z, Huang S, Gu J, Li J, et al. MiR-199a-5p is negatively associated with malignancies and regulates glycolysis and lactate production by targeting hexokinase 2 in liver cancer. Hepatology. 2015;62(4):1132–1144. doi:10.1002/hep.27929
  • Klingenberg M, Matsuda A, Diederichs S, Patel T. Non-coding RNA in hepatocellular carcinoma: mechanisms, biomarkers and therapeutic targets. J Hepatol. 2017;67(3):603–618. doi:10.1016/j.jhep.2017.04.009
  • Shang R-Z, Qu S-B, Wang D-S. Reprogramming of glucose metabolism in hepatocellular carcinoma: progress and prospects. World J Gastroenterol. 2016;22(45):9933–9943. doi:10.3748/wjg.v22.i45.9933
  • Wu H, Wang Y, Wu C, Yang P, Li H, Li Z. Resveratrol induces cancer cell apoptosis through MiR-326/PKM2-mediated ER stress and mitochondrial fission. J Agric Food Chem. 2016;64(49):9356–9367. doi:10.1021/acs.jafc.6b04549
  • Pollutri D, Gramantieri L, Bolondi L, Fornari F. TP53/microRNA interplay in hepatocellular carcinoma. Int J Mol Sci. 2016;17(12):2029. doi:10.3390/ijms17122029
  • Chen L, Zhang C, Wang Y, Li Y, Han Q, Yang H, Zhu Y. Data mining and pathway analysis of glucose-6-phosphate dehydrogenase with natural language processing. Mol Med Rep. 2017;16(2):1900–1910. doi:10.3892/mmr.2017.6785
  • Cannell I, Bushell M. Regulation of Myc by miR-34c: a mechanism to prevent genomic instability? Cell Cycle. 2010;9(14):2798–2802. doi:10.4161/cc.9.14.12182
  • Li C, Zhang G, Zhao L, Ma Z, Chen H. Metabolic reprogramming in cancer cells: glycolysis, glutaminolysis, and Bcl-2 proteins as novel therapeutic targets for cancer. World J Surg Oncol. 2015;14(1):15. doi:10.1186/s12957-016-0769-9 
  • Gao P, Tchernyshyov I, Chang T-C, Lee Y-S, Kita K, Ochi T, Zeller KI, De Marzo AM, Van Eyk JE, Mendell JT, et al. c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature. 2009;458(7239):762–765. doi:10.1038/nature07823
  • Jin L, Alesi GN, Kang S. Glutaminolysis as a target for cancer therapy. Oncogene. 2016;35(28):3619–3625. doi:10.1038/onc.2015.447
  • Goetzman ES, Prochownik EV. The role for Myc in coordinating glycolysis, oxidative phosphorylation, glutaminolysis, and fatty acid metabolism in normal and neoplastic tissues. Front Endocrinol. 2018;9:129. doi:10.3389/fendo.2018.00129
  • Nazari S, Rameshrad M, Hosseinzadeh H. Toxicological effects of Glycyrrhiza glabra (licorice): a review. Phytother Res. 2017;31(11):1635–1650. doi:10.1002/ptr.5893
  • Omar HR, Komarova I, El-Ghonemi M, Fathy A, Rashad R, Abdelmalak HD, Yerramadha MR, Ali Y, Helal E, Camporesi EM, et al. Licorice abuse: time to send a warning message. Ther Adv Endocrinol Metab. 2012;3(4):125–138. doi:10.1177/2042018812454322
  • Park J-K, Kogure T, Nuovo GJ, Jiang J, He L, Kim JH, Phelps MA, Papenfuss TL, Croce CM, Patel T, et al. miR-221 silencing blocks hepatocellular carcinoma and promotes survival. Cancer Res. 2011;71(24):7608–7616. doi:10.1158/0008-5472.CAN-11-1144
  • Negrini M, Gramantieri L, Sabbioni S, M, Croce C. microRNA involvement in hepatocellular carcinoma. Anticancer Agents Med Chem. 2011;11(6):500–521. doi:10.2174/187152011796011037
  • Garofalo M, Quintavalle C, Romano G, Croce CM, Condorelli G. miR221/222 in cancer: their role in tumor progression and response to therapy. Curr Mol Med. 2012;12(1):27–33. doi:10.2174/156652412798376170

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.